miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2013 |
| Author/s |
author: Rosamonde Elizabeth Banks David Robert Mole Adrian Harris |
| Publication date | February 28, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |